Digitalization Gap Splits Germany’s Pharma and Chemical Giants, Study Shows

New study reveals Bayer and Merck lead digital transformation in Germany's €55B chemical and pharma sector, while others lag behind. Industry partnerships and AI workflows emerge as key drivers.

A fresh industry snapshot has exposed a deep divide in how Germany’s chemical and pharmaceutical companies handle digital transformation. Instinctif Partners released a study on June 5 ranking Bayer AG and Merck KGaA as frontrunners, while Celesio AG and AbbVie Deutschland failed to earn any stars. BASF and Linde each received four stars.

The stakes are enormous. Germany’s pharmaceutical sector contributes roughly €55 billion to the national economy every year, with about 20 percent of revenue plowed into research and development. Those numbers, combined with rising regulatory demands, make efficient digital workflows a bottom-line necessity.

Some players are racing ahead. The Klosterfrau Healthcare Group rolled out a company-wide contract management system dubbed “iCO – Intelligent Contracting” in just six months. Built by HMP Solutions GmbH, the platform handles contract templates, deadlines and risk management centrally, aiming to digitize the entire contract lifecycle and improve cross-department communication.

US-based DocuSign is also riding the wave. On June 4 the company reported a nine percent revenue increase to $830.2 million, powered by its AI-driven “Intelligent Agreement Management” platform. Despite raising its forecasts, the stock market response was muted.

To meet the technical challenge, firms are forging alliances. On June 5 Hyland and Microsoft announced a partnership to place Hyland’s content solutions on Azure, with a focus on AI-powered workflows and compliance. Separately, Syensqo kicked off a multi-year transformation project to migrate to SAP S/4HANA, backed by Syniti and Capgemini. Capgemini reported global revenue of €22.5 billion in 2025.

The health-care sector is not standing still. On June 1, Klinikum Darmstadt and AGAPLESION Elisabethenstift merged to create the “Südhessen Kliniken”. From 2027, construction work and a joint market presence are planned. Meanwhile, IT systems built on the FHIR standard are gaining traction, pulling real-time data from different departments and medical devices to support clinical decisions and boost efficiency—for example, through digital patient guidance in endoprosthetics.